Biogen | BIIB - Creditori Commerciali





Creditori Commerciali Cambiamento Data
AbbVie USD 3.59B 28.65B 2025-12
Acadia Pharmaceuticals USD 10.9M 10.84M 2025-12
ALKERMES USD 107.95M 39.95M 2025-12
Amgen USD 20.89B 1.25B 2025-12
Bayer EUR 7.08B 700M 2025-12
Biogen USD 358.5M 73.5M 2026-03
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Eli Lilly USD 5.38B 1.12B 2025-12
Esperion Therapeutics USD 65.07M 12.44M 2025-12
Gilead Sciences USD 715M 93M 2025-12
Incyte USD 228.62M 1.41B 2026-03
Merck USD 4.15B 102M 2025-09
Moderna USD 317M 50M 2025-12
Neurocrine Biosciences USD 545.5M 425.6M 2025-12
Novartis USD 4.46B 99M 2025-12
Pfizer USD 5.02B 142M 2025-09
PTC Therapeutics USD 45.49M 8.87M 2025-12
Puma Biotechnology USD 6.39M 962K 2025-09
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sanofi EUR 22.71B 219M 2026-03
Sanofi EUR 22.93B 2.89B 2025-12
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
Teva Pharmaceutical Industries USD 2.53B 176M 2025-12
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
United Therapeutics USD 7.1M 460.9M 2025-12
Vertex Pharmaceuticals USD 3.43B 600.9M 2025-12